In recent reports, novel star-shaped PCL-b-PEG nanoparticle systems containing glucose molecules and anti-nucleolin aptamers conjugated to the semicrystalline core block and PEG corona, respectively, were designed for the targeted delivery of both cisplatin (CIS) and anti-miR-214 LNAs to CIS-resistant ovarian tumours [248]. Here, NUCLEOLIN is linked to in situ carcinoma.